Role of the androgen receptor in human breast cancer, Journal of Mammary Gland Biology and Neoplasia, vol.3, issue.1, pp.95-103, 1998. ,
DOI : 10.1023/A:1018730519839
Expression of androgen receptors in primary breast cancer, Annals of Oncology, vol.21, issue.3, pp.488-492, 2010. ,
DOI : 10.1093/annonc/mdp510
Identification of molecular apocrine breast tumours by microarray analysis, Oncogene, vol.268, issue.29, pp.4660-4671, 2005. ,
DOI : 10.1023/A:1006356502820
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen, Oncogene, vol.62, issue.28, pp.3994-4008, 2006. ,
DOI : 10.1038/sj.onc.1209415
A refined molecular taxonomy of breast cancer, Oncogene, vol.10, issue.9, pp.1196-1206, 2012. ,
DOI : 10.1038/nature09515
URL : https://hal.archives-ouvertes.fr/inserm-00611752
Androgen receptors frequently are expressed in breast carcinomas, Cancer, vol.29, issue.4, pp.703-711, 2003. ,
DOI : 10.1002/cncr.11532
citbcmst: Assigning tumor samples to CIT Breast Cancer Molecular Subtypes from gene expression data ,
Evaluation of androgen, estrogen (ER? and ER?), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays, Cancer Res, vol.61, pp.1919-1926, 2001. ,
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization, PLoS ONE, vol.28, issue.8, p.51862, 2012. ,
DOI : 10.1371/journal.pone.0051862.s001
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches, British Journal of Cancer, vol.131, issue.11, pp.1739-1746, 2011. ,
DOI : 10.1159/000055396
A simple p53 functional assay for screening cell lines, blood, and tumors., Proceedings of the National Academy of Sciences, vol.92, issue.9, pp.3963-3967, 1995. ,
DOI : 10.1073/pnas.92.9.3963
Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tract, Oncogene, vol.14, issue.2, pp.163-169, 1997. ,
DOI : 10.1038/sj.onc.1200812
p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors, International Journal of Cancer, vol.104, issue.4, pp.53991-997, 2009. ,
DOI : 10.1002/ijc.24049
URL : https://hal.archives-ouvertes.fr/inserm-00498765
PIK3CA Mutations and BRCA1 Expression in Breast Cancer: Potential Biomarkers for Chemoresistance, Cancer Investigation, vol.13, issue.24, pp.1044-1051, 2008. ,
DOI : 10.4161/cbt.3.12.1388
College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, College of American Pathologists Arch Pathol Lab Med, vol.131, pp.18-43, 2007. ,
Current issues in ER and HER2 testing by IHC in breast cancer, Modern Pathology, vol.5, issue.2, pp.8-15, 2008. ,
DOI : 10.1309/FUQH-92B0-3902-5LHG
Classification and Regression Trees London: Chapman and Hall, 1984. ,
Selecting the best splits for classification trees with categorical variables, Statistics & Probability Letters, vol.54, issue.4, pp.341-345, 2001. ,
DOI : 10.1016/S0167-7152(00)00188-7
R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing, 2009. ,
Tree: Classifcation and Regression Trees 2010. R package version 1.0- 28 ,
Ductal carcinoma in situ of the breast with apocrine cytology: Definition of a borderline category, Human Pathology, vol.25, issue.2, pp.164-168, 1994. ,
DOI : 10.1016/0046-8177(94)90273-9
Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases, Mod Pathol, vol.7, pp.813-818, 1994. ,
World Health Organization: Tumours of the Breast and Female Genital Organs -Pathology and, 2003. ,
The enigmatic nature of apocrine breast lesions, Virchows Archiv, vol.193, issue.2, pp.525-531, 2006. ,
DOI : 10.1007/s00428-005-0095-z
Refinement of breast cancer classification by molecular characterization of histological special types, The Journal of Pathology, vol.9, issue.2, pp.141-150, 2008. ,
DOI : 10.1002/path.2407
Molecular characterization of apocrine carcinoma of the breast: Validation of an apocrine protein signature in a well-defined cohort, Molecular Oncology, vol.14, issue.1, pp.220-237, 2009. ,
DOI : 10.1016/j.molonc.2009.01.005
ER-??36, a novel isoform of ER-??66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast, Journal of Clinical Pathology, vol.64, issue.1, pp.54-57, 2011. ,
DOI : 10.1136/jcp.2010.082776
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation, Modern Pathology, vol.10, issue.2, pp.205-212, 2010. ,
DOI : 10.1016/S0002-9610(03)00054-0
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours, Breast Cancer Research, vol.20, issue.3, p.40, 2009. ,
DOI : 10.1016/j.ceb.2008.02.003
Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation, Journal of Cellular Physiology, vol.104, issue.5, pp.2276-2282, 2012. ,
DOI : 10.1002/jcp.22966
Gross cystic disease fluid protein-15 as a marker for breast cancer: Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin, Human Pathology, vol.20, issue.3, pp.281-287, 1989. ,
DOI : 10.1016/0046-8177(89)90137-8
Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer, Clinical Cancer Research, vol.15, issue.7, pp.2472-2478, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1763
Expression of Androgen Receptor Is Negatively Regulated By p53, Neoplasia, vol.9, issue.12, pp.1152-1159, 2007. ,
DOI : 10.1593/neo.07769
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study, Modern Pathology, vol.10, issue.7, pp.924-931, 2011. ,
DOI : 10.1093/jnci/djp082
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy, Breast Cancer Research and Treatment, vol.28, issue.6, pp.477-487, 2011. ,
DOI : 10.1007/s10549-011-1715-8
Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors, BMC Cancer, vol.25, issue.1, p.149, 2008. ,
DOI : 10.1677/jme.0.0250085
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women, Clinical Cancer Research, vol.17, issue.7, pp.1867-1874, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-2021
Androgen Receptor Expression in Estrogen Receptor???Negative Breast Cancer, American Journal of Clinical Pathology, vol.120, issue.5, pp.725-731, 2003. ,
DOI : 10.1309/42F00D0DJD0J5EDT
Expression and clinical significance of androgen receptor in triple negative breast cancer, Chinese Journal of Cancer, vol.29, issue.6, pp.585-590, 2010. ,
DOI : 10.5732/cjc.009.10673
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations, Breast Cancer Research, vol.15, issue.4, p.63, 2010. ,
DOI : 10.1038/nm.2000
URL : https://hal.archives-ouvertes.fr/hal-00698403
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, Journal of Clinical Investigation, vol.121, issue.7, pp.2750-2767, 2011. ,
DOI : 10.1172/JCI45014DS1